Compare TMUS & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMUS | NVO |
|---|---|---|
| Founded | 1994 | 1923 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.3B | 212.7B |
| IPO Year | N/A | N/A |
| Metric | TMUS | NVO |
|---|---|---|
| Price | $197.56 | $50.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $265.20 | $54.25 |
| AVG Volume (30 Days) | 4.9M | ★ 18.5M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | 2.09% | ★ 2.45% |
| EPS Growth | ★ 18.54 | 10.06 |
| EPS | ★ 10.38 | 3.67 |
| Revenue | ★ $85,847,000,000.00 | $49,580,393,058.00 |
| Revenue This Year | $10.53 | $7.77 |
| Revenue Next Year | $7.36 | $1.86 |
| P/E Ratio | $18.80 | ★ $13.69 |
| Revenue Growth | 7.30 | ★ 16.64 |
| 52 Week Low | $194.01 | $43.08 |
| 52 Week High | $276.49 | $111.17 |
| Indicator | TMUS | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 55.60 |
| Support Level | $194.01 | $46.08 |
| Resistance Level | $211.63 | $50.75 |
| Average True Range (ATR) | 4.28 | 1.07 |
| MACD | -0.86 | 0.54 |
| Stochastic Oscillator | 19.44 | 91.89 |
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 85 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers with its wireless network. It also serves nearly 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.